New research done by Texas A&M Ph.D. student Ryan Clanton has found a way to turn one of the most common progenitors of disease, microbes, into an ally in the fight against cancer.
Some of the groundbreaking discoveries do not successfully move from the bench to the bedside because researchers find they have limited training when it comes to commercialization.